|
|
Top Story |
 |
Preparing Supply Chains for Brexit |
Despite the uncertainty, there is plenty of work to be done to reduce risk in supply chains ahead of the UK's exit from the European Union, write Johnathon Marshall and Chris Cartmell
... /Read more/ |
|
|
Adherence |
 |
Patient Adherence and Human Nature |
We need to look to behavioral science to deconstruct the psychological barriers that make patients act in ways that can seem irrational and self-defeating, writes Jim O'Donoghue ... /Read more/ |
|
|
|
Calendar |
/ May 10–11: Pharma Marketing Summit / |
Palm Beach, FL |
/ May 23: Artificial Intelligence for Drug Discovery / |
Cambridge, MA |
/ June 5–7: Pharmaceutical Compliance Congress Canada / |
Toronto, Canada |
/ June 13–14: Connected Devices in Life Sciences / |
Boston, MA |
/ June 14: GTN Bootcamp for Bioscience Companies / |
San Francisco, CA |
/ June 19–20: Rare Disease Innovation Summit / |
Boston, MA |
/ June 21–22: Disruptive Downstream Technologies / |
San Diego, CA |
/ August 7–8: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
Philadelphia, PA |
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
National Harbor, MD |
/ November 13–14: Commercial Data Insights 2018 / |
Philadelphia, PA |
/ November 13¬–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
Philadelphia, PA |
/ November 14–15: Compliant Patient Support Programs Summit / |
Chicago, IL |
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
London, UK |
/ December 4–5: Managed Markets Compliance Congress 2018 / |
Philadelphia, PA |
|
|
|
Industry update |
//
NeoPhore (Cambridge, UK) announced the appointment of Jeffrey Roix as Chief Executive Officer.
//
Glythera (Newcastle, UK) appointed Professor Kerry Chester to its Scientific Advisory Board.
//
Concept Life Sciences (Manchester, UK) appointed Matilda Bingham as Site Director of its Alderley Park, UK site and David Higton as Principal Scientist (Biotransformation and Metabolite Identification), also at the Alderley Park site.
//
Dr. Richard Beckman joined ReNeuron (Bridgend, UK) as Chief Medical Officer. Dr. Beckman will be based in ReNeuron's recently established US office in Boston, MA, where he will lead the company's clinical and medical affairs team.
//
Lysogene (Cambridge, MA, and Paris, France) appointed Dr. Peter Lichtlen to the Board of Directors, as a non-executive, independent member.
//
Pharnext (Paris, France) announced the appointment of Amit Kohli as Chief Operating Officer.
//
Ivana Magovčević-Liebisch, Ph.D, J.D. joined Ipsen (Paris, France) as Executive Vice-President, Chief Business Officer. Régis Mulot also joined the company as Executive Vice-President, Chief Human Resources Officer.
//
|
|
|
|